Rafael Ramos

Gastrointestinal Stromal Tumors: Review on Morphology, Molecular Pathology, Prognosis, and Differential Diagnosis

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis

Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies

Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives

Cell Signaling by Receptor Tyrosine Kinases

Nomograms in oncology: more than meets the eye

Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing

B-cell depletion with rituximab in the treatment of autoimmune diseases

Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 cases

A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region

Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)

Gastrointestinal stromal tumor (GIST) pathogenesis, familial GIST, and animal models

Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours

Targeting apoptosis in cancer therapy

KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs)

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

PROTAC targeted protein degraders: the past is prologue

Diagnosis and multi-disciplinary management of hepatic metastases from gastrointestinal stromal tumour (GIST)

Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative

Microscopic Gastrointestinal Stromal Tumors in Esophageal and Intestinal Surgical Resection Specimens

NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors

Helping the Released Guardian: Drug Combinations for Supporting the Anticancer Activity of HDM2 (MDM2) Antagonists

Molecular Pathobiology of Gastrointestinal Stromal Sarcomas

RG7112, a Small-Molecule Inhibitor of MDM2, Enhances Trabectedin Response in Soft Tissue Sarcomas

Pathogenic study of anti-CD20 infusion-related severe refractory shock in diffuse large B-cell lymphoma

Deletions Affecting Codons 557-558 of the c-KIT Gene Indicate a Poor Prognosis in Patients With Completely Resected Gastrointestinal Stromal Tumors: A Study by the Spanish Group for Sarcoma Research (GEIS)